RE-LIEVED LIDOCAINE PATCH- lidocaine patch 4% patch 
Transfer Technology

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Re-Lieved Lidocaine 4% Patch

Active Ingredients

Lidocaine 4%

Menthol 1%

Purpose

Topical Analgesic

Use

For the temporary relief of pain.

Warnings

For external use only. The adhesoin properties of this patch may cause an extended period of redness. Please visit www.re-lieved.com for more information.

Do not use

If you are allergic to Lidocaine. On open wounds or on damaged, broken or irritated skin. Remove immidiately if you sense a burning sensation after application.

When using this product

Ask your doctor or pharmacist before use if you are

using blood thinning medication, steroids, or non-steroidal anti-inflammatory druns (NSAIDs), or if you have sensitive skin.

Stop use or ask a doctor if

If pregnant or breast feeding

ask a physician before use.

Keep out of reach of children

If put in mouth, get medical help or contact a poison control center right away. Dispose of used product away from children and pets.

Directions adults/children 12 years or older

Other information

Inactive Ingredients

Acrylic adhesive, Polyethylene fabric

Re-Lieved Lidocaine-Menthol

Re-Lieved Lidocaine plus Menthol

RE-LIEVED LIDOCAINE PATCH 
lidocaine patch 4% patch
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:71662-001
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
MENTHOL, (+)- (UNII: C6B1OE8P3W) (MENTHOL, (+)- - UNII:C6B1OE8P3W) MENTHOL, (+)-1 mg  in 100 mg
LIDOCAINE (UNII: 98PI200987) (LIDOCAINE - UNII:98PI200987) LIDOCAINE4 mg  in 100 mg
Inactive Ingredients
Ingredient NameStrength
ACRYLIC ACID/ETHYLENE COPOLYMER (600 MPA.S) (UNII: 1PEZ3NLY6I)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:71662-001-065 mg in 1 POUCH; Type 0: Not a Combination Product02/01/2021
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart34802/01/2021
Labeler - Transfer Technology (037968132)
Registrant - Transfer Technology (037968132)
Establishment
NameAddressID/FEIBusiness Operations
Transfer Technoloy037968132manufacture(71662-001)

Revised: 1/2021
Document Id: ba5cd48c-cd44-2f63-e053-2a95a90a930f
Set id: ba5cd48c-cd43-2f63-e053-2a95a90a930f
Version: 1
Effective Time: 20210120
 
Transfer Technology